000 | 00883nas a2200277 a 4500 | ||
---|---|---|---|
001 | u29825 | ||
003 | SIRSI | ||
005 | 20180219125227.0 | ||
008 | 021013c19789999gw qx1p b 0 a0eng d | ||
022 | _a0344-5704 | ||
030 | _aCCPHDZ | ||
039 | 9 |
_a200310181321 _beman _y200210131633 _zsafaa |
|
050 |
_aRC271.C5 _bC53 |
||
210 | 0 | _aCancer chemother. pharmacol. | |
222 | 0 | _aCancer chemotherapy and pharmacology | |
245 | 0 | 0 | _aCancer chemotherapy and pharmacology. |
260 |
_aBerlin ; _aNew York : _bSpringer International, |
||
300 |
_av. : _bill. ; _c28 cm. |
||
310 | _aFour no. a year | ||
362 | 1 | _aBegan with v. 1, no. 1 (1978)- | |
500 | _aDescription based on: Vol. 16, no. 1 (Jan. 1986) | ||
596 | _a1 | ||
650 | 0 |
_aCancer _xChemotherapy _vPeriodicals. |
|
650 | 0 |
_aAntineoplastic agents _vPeriodicals |
|
942 |
_cCR _2lcc |
||
999 |
_c13459 _d13459 |